{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-041254","form_type":"8-K","ticker":"CRBP","cik":"0001595097","company_name":"Corbus Pharmaceuticals Holdings, Inc.","filed_at":"2025-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.111896+00:00","generated_at":"2026-05-24T13:40:26.363218+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Corbus appoints Ian Hodgson as COO effective March 15, 2025","bullets":["Ian Hodgson, 52, previously Head of Operations, named COO effective March 15, 2025.","Annual base salary of £327,869; eligible for annual bonus up to 40% of base salary.","Employment subject to 3-month notice period; non-compete for 3 months, non-solicit for 6 months post-termination.","Dr. Hodgson holds a PhD in Medical Microbiology, over 25 years experience in drug development."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-041254","json":"https://secwatch.observer/filing/0000950170-25-041254.json","markdown":"https://secwatch.observer/filing/0000950170-25-041254.md","text":"https://secwatch.observer/filing/0000950170-25-041254.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025041254/0000950170-25-041254-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025041254/crbp-20250313.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T13:40:26.363218+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ed84d3b22c","claim":"Ian Hodgson was appointed as Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc..","evidence_excerpt":"On March 13, 2025, the Board of Directors (the “Board”) of Corbus Pharmaceuticals Holdings, Inc. (the “Company”) appointed Ian Hodgson as Chief Operating Officer effective March 15, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025041254/0000950170-25-041254-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}